Endovascular Engineering, Inc. (\"E2\") is a US-based venture-backed company established in 2019. The company is dedicated to creating innovative vascular thrombectomy solutions, with a focus on developing and deploying groundbreaking clot removal technologies targeting venous thromboembolism. E2 recently secured a significant $15.00M Series A investment on April 05, 2022, with the round led by Santé Ventures and Cordis. This latest investment signifies confidence and support from established players in the healthcare and venture capital space, paving the way for E2's continued growth and expansion in the field of endovascular engineering.
General Information
BounceWatch is an independent company data service, not affiliated with Endovascular Engineering. To contact Endovascular Engineering, visit endovascularengineering.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Endovascular Engineering compare?
A PDF of Endovascular Engineering and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Endovascular Engineering soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Medical Devices
About Endovascular Engineering
Business keywords: vascular thrombectomy, clot removal technologies, venous thromboembolism, endovascular, innovation, preclinical stage, mechanical thrombectomy, peripheral indications, interventional medicine, investor-backed, medical innovation, vascular health
Funding Rounds & Investors (1)
View AllEndovascular Engineering Alternatives & Competitors
View All AlternativesImproving lives in extraordinary ways by creating innovative solutions for both unmet and underserve...
Changing the paradigm on treating chronic venous disease.
Innovators in Vascular Technologies
FAQ About Endovascular Engineering
Source: BounceWatch company record for Endovascular Engineering, https://bouncewatch.com/company/endovascular-engineering, updated 19 December 2024. When citing, please name BounceWatch and link this page.